Arkolith/Insider Trading/AERI/Form 4

Calabrese Jeffrey

Vice President of FinanceAERIE PHARMACEUTICALS INC (AERI) · full profile →Form 4 · filed Nov 21, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2022Disposed to issuer(D)19K$15.25$283K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 21, 2022Disposed to issuer(D)21K$6.89$143K0
Nov 21, 2022Disposed to issuer(D)6K$4.23$26K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-058160) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML